πŸ‡ΊπŸ‡Έ FDA
Patent

US 8193352

Gyrase inhibitors and uses thereof

granted A61PA61P31/04

Quick answer

US patent 8193352 (Gyrase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P31/04